Alexion to buy Swedish biotech Wilson Therapeutics for $855 mln

April 11 (Reuters) - Alexion Pharmaceuticals said on Wednesday it had agreed to buy Sweden's Wilson Therapeutics for 7.1 billion Swedish crowns ($855 million) to boost its line-up of rare disease drugs.